Events
Martinsried/Munich Medigene AG, a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, reports on the Company’s Annual General Meeting which was held in Munich.
GeoVax Selected by NIH and BIO to Showcase its Technology as Part of the BIO Innovation Zone
Motif Bio plc, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that at the Company’s AGM held earlier the Company provided the following review of key aspects of its business and growth strategy.
Objective responses, good safety and evidence of stimulation of the immune system observed under murlentamab (GM102) single agent and in combination with chemotherapy
Promore Pharma AB held its AGM on Tuesday, 21 May 2019.
Heidelberg Pharma AG announced that the shareholders of the Company approved the resolutions of the administration with large majorities during the Annual General Meeting.
Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESOC 2019
Medigene AG, a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, will present data from the interim analysis of the ongoing Phase I / II clinical trial with Medigene’s DC vaccine during the annual congress of the European Hematology Association taking place from 13 - 16 June in Amsterdam.
Polyphor AG announced that it will present new clinical data on survival outcomes of the Phase I trial of balixafortide, our lead immuno-oncology candidate, in combination with eribulin in HER2 negative metastatic breast cancer at the 2019 American Society of Clinical Oncology Annual Meeting being held in Chicago, May 31 - June 4, 2019.
Recognizing the Support of the National Institutes of Health and the
PRESS RELEASES